Meta-Analysis of Efficacy of Sacubitril/Valsartan in Heart Failure With Preserved Ejection Fraction

Am J Cardiol. 2021 Apr 15:145:165-168. doi: 10.1016/j.amjcard.2021.01.013. Epub 2021 Jan 30.

Authors

Husam M Salah¹, Marat Fudim², Subhi J Al'Aref¹, Muhammad Shahzeb Khan³, Zaid I Almarzooq⁴, Subodh R Devabhaktuni¹, Robert J Mentz², Javed Butler³, Stephen J Greene⁵

Affiliations

¹ Division of Cardiology, Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
² Division of Cardiology, Duke University School of Medicine, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina.
³ Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi.
⁴ Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, Massachusetts.
⁵ Division of Cardiology, Duke University School of Medicine, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina. Electronic address: stephen.greene@duke.edu.

PMID: 33529619
DOI: 10.1016/j.amjcard.2021.01.013

No abstract available

Publication types

Letter
Meta-Analysis
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Aminobutyrates / therapeutic use*
Angiotensin Receptor Antagonists / therapeutic use*
Biphenyl Compounds
Cause of Death
Drug Combinations
Heart Failure / blood
Heart Failure / drug therapy*
Heart Failure / physiopathology
Hospitalization
Humans
Mortality
Natriuretic Peptide, Brain / blood
Peptide Fragments / blood
Severity of Illness Index
Stroke Volume
Tetrazoles / therapeutic use*
Treatment Outcome
Valsartan

Substances

Aminobutyrates
Angiotensin Receptor Antagonists
Biphenyl Compounds
Drug Combinations
Peptide Fragments
Tetrazoles
pro-brain natriuretic peptide (1-76)
Natriuretic Peptide, Brain
Valsartan
sacubitril and valsartan sodium hydrate drug combination